Meeting
2020 ASCO Virtual Scientific Program
Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
Authors
Stephen V. Liu
Georgetown University, Washington, DC
Stephen V. Liu , Ari M. Vanderwalde , Hirva Mamdani , Luis E. Raez , Yasmine Baca , Joanne Xiu , Wolfgang Michael Korn , Misako Nagasaka , Sachin Gopalkrishna Pai , Mark A. Socinski , Jorge J. Nieva , Chul Kim , Antoinette J. Wozniak , Chukwuemeka Ikpeazu Sr., Gilberto Lopes , Alexander I. Spira , Julia Judd , Edward S. Kim , Hossein Borghaei
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 38: 2020 (suppl; abstr 9544)
DOI
10.1200/JCO.2020.38.15_suppl.9544
Abstract #
9544
Poster Bd #
310
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2020 ASCO Virtual Scientific Program
Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS–mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).
First Author: Yutaro Tamiya
Poster
2023 ASCO Annual Meeting
Co-mutational status and PD-L1 expression in KRAS mutant non-small cell lung cancer (NSCLC): Role in treatment selection and association with clinical outcomes.
First Author: Hina Khan
Poster
2023 ASCO Annual Meeting
The impact of PD-L1 expression and co-mutations on outcome of KRAS-driven non-small-cell lung cancer.
First Author: Petros Christopoulos